193 related articles for article (PubMed ID: 36919394)
21. Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease.
Hanneken S; Rütten A; Pasternack SM; Eigelshoven S; El Shabrawi-Caelen L; Wenzel J; Braun-Falco M; Ruzicka T; Nöthen MM; Kruse R; Betz RC
Br J Dermatol; 2010 Jul; 163(1):197-200. PubMed ID: 20222933
[TBL] [Abstract][Full Text] [Related]
22. Three cases of Dowling Degos disease in two families.
Bhagwat PV; Tophakhane RS; Shashikumar BM; Noronha TM; Naidu V
Indian J Dermatol Venereol Leprol; 2009; 75(4):398-400. PubMed ID: 19584468
[TBL] [Abstract][Full Text] [Related]
23. Generalized Dowling-Degos disease.
Wu YH; Lin YC
J Am Acad Dermatol; 2007 Aug; 57(2):327-34. PubMed ID: 17637446
[TBL] [Abstract][Full Text] [Related]
24. Dowling-Degos disease involving the vulva and back: case report and review of the literature.
Horner ME; Parkinson KE; Kaye V; Lynch PJ
Dermatol Online J; 2011 Jul; 17(7):1. PubMed ID: 21810386
[TBL] [Abstract][Full Text] [Related]
25. Treatment of Dowling-Degos disease with fractional Er:YAG laser.
Yun JH; Kim JH; Choi JS; Roh JY; Lee JR
J Cosmet Laser Ther; 2013 Dec; 15(6):336-9. PubMed ID: 23464495
[TBL] [Abstract][Full Text] [Related]
26. Dowling-Degos Disease with Follicular Involvement Associated with Hidradenitis Suppurativa: A Manifestation of Follicular Occlusion Phenomenon?
Supekar BB; Rambhia KD; Singh RP; Mukhi JI
Indian J Dermatol; 2020; 65(4):295-298. PubMed ID: 32831371
[TBL] [Abstract][Full Text] [Related]
27. Dowling-Degos disease: a review.
Stephan C; Kurban M; Abbas O
Int J Dermatol; 2021 Aug; 60(8):944-950. PubMed ID: 33368260
[TBL] [Abstract][Full Text] [Related]
28. Dowling-Degos disease.
Georgescu EF; Stănescu L; Popescu CF; Comănescu M; Georgescu I
Rom J Morphol Embryol; 2010; 51(1):181-5. PubMed ID: 20191141
[TBL] [Abstract][Full Text] [Related]
29. Atypical Disseminated Variant of Galli-Galli Disease: A Review of the Literature.
Yang A; Cheung K; Kossard S; Murrell DF
Am J Dermatopathol; 2020 Jul; 42(7):484-490. PubMed ID: 31449063
[TBL] [Abstract][Full Text] [Related]
30. Hidradenitis Suppurativa Associated with Galli-Galli Disease: Extending the Link with Dowling-Degos Disease.
Del Mar M; González M; Sayed C; Phadke P
J Clin Aesthet Dermatol; 2020 Dec; 13(12):38-40. PubMed ID: 33488918
[TBL] [Abstract][Full Text] [Related]
31. A case of Dowling-Degos disease suggesting an evolutional sequence.
Lee SJ; Lee HJ; Kim DW; Jun JB; Chung SL; Bae HI
J Dermatol; 2000 Sep; 27(9):591-7. PubMed ID: 11052235
[TBL] [Abstract][Full Text] [Related]
32. The expanding spectrum of Galli-Galli disease.
El Shabrawi-Caelen L; Rütten A; Kerl H
J Am Acad Dermatol; 2007 May; 56(5 Suppl):S86-91. PubMed ID: 17434047
[TBL] [Abstract][Full Text] [Related]
33. Dowling-Degos Disease with Hidradenitis Suppurativa and Inflammatory Arthritis in Two Generations.
George A; George R; Mathew AJ; Telugu RB
Indian Dermatol Online J; 2020; 11(3):413-415. PubMed ID: 32695705
[TBL] [Abstract][Full Text] [Related]
34. Reticulate acropigmentation of Dohi: a case report of autosomal recessive inheritance.
Alfadley A; Al Ajlan A; Hainau B; Pedersen KT; Al Hoqail I
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):113-7. PubMed ID: 10863235
[TBL] [Abstract][Full Text] [Related]
35. Dowling-Degos Disease Presenting With Associated Epidermal Inclusion Cysts: A Case Report and Review of the Literature.
Marinelli KC; Marinelli LM; Roberts AM; Lincoln MS
Am J Dermatopathol; 2022 Mar; 44(3):e29-e32. PubMed ID: 34816802
[TBL] [Abstract][Full Text] [Related]
36. The spectrum of reticulate pigment disorders of the skin revisited.
Müller CS; Tremezaygues L; Pföhler C; Vogt T
Eur J Dermatol; 2012; 22(5):596-604. PubMed ID: 23018017
[TBL] [Abstract][Full Text] [Related]
37. Exacerbation of Galli-Galli Disease Following Dialysis Treatment: A Case Report and Review of Aggravating Factors.
Joshi TP; Shaver S; Tschen J
Cureus; 2021 Jun; 13(6):e15401. PubMed ID: 34249550
[TBL] [Abstract][Full Text] [Related]
38. Whole-exome sequencing identifies ADAM10 mutations as a cause of reticulate acropigmentation of Kitamura, a clinical entity distinct from Dowling-Degos disease.
Kono M; Sugiura K; Suganuma M; Hayashi M; Takama H; Suzuki T; Matsunaga K; Tomita Y; Akiyama M
Hum Mol Genet; 2013 Sep; 22(17):3524-33. PubMed ID: 23666529
[TBL] [Abstract][Full Text] [Related]
39. Reticulate nonmelanocytic hyperpigmentation anomaly. A probable variant of Dowling-Degos disease.
Oriba HA; Lo JS; Dijkstra JW; Bergfeld WF
Int J Dermatol; 1991 Jan; 30(1):39-42. PubMed ID: 1993563
[TBL] [Abstract][Full Text] [Related]
40. Disseminated papular variant of Dowling-Degos disease: Histopathological features in POGLUT1 mutation.
Papadopoulou K; Karsai S; Böer-Auer A
J Dtsch Dermatol Ges; 2022 Nov; 20(11):1423-1429. PubMed ID: 36314591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
